Related Experiment Video
Updated: Apr 26, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Pre-plan parameters predict post-implant D90 ≥ 140 Gy for (125)I permanent prostate implants
Jes Alexander1, Vivian Weinberg2, Alexander R Gottschalk1
1Department of Radiation Oncology, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.
Pre-plan dosimetry for permanent prostate implant (PPI) can predict outcomes. Larger anterior margins and higher seed occupancy predict a D90 of at least 140 Gy, crucial for effective prostate cancer treatment.
Area of Science:
- Radiation Oncology
- Medical Physics
- Urologic Oncology
Background:
- Permanent prostate implant (PPI) brachytherapy is a treatment for low or intermediate-risk prostate cancer.
- Achieving adequate radiation dose (D90) is critical for treatment efficacy.
- Predictive dosimetric parameters from pre-treatment planning are needed to optimize outcomes.
Purpose of the Study:
- To identify pre-plan dosimetric parameters that predict a post-implant D90 of ≥ 140 Gy.
- To improve the precision of permanent prostate implant (PPI) planning.
Main Methods:
- Analysis of pre-plans for 504 patients undergoing (125)I PPI.
- Evaluation of seed numbers, occupancy proportions, and margin distances across various prostate segments.
- Correlation of pre-plan parameters with post-implant D90 (≥ 140 Gy vs. < 140 Gy).
Main Results:
- 20% of patients had a post-implant D90 < 140 Gy.
- Higher anterior D90 (AT, IA) seed counts and larger anterior/mid-gland margins (WP, S, A, SA, ST, AT, MT) were associated with D90 ≥ 140 Gy.
- Reduced posterior segment (PT) occupancy proportion and smaller posterior margins (P) were also noted in the higher D90 group.
Conclusions:
- Pre-plan parameters, specifically anteriorly placed seeds and larger margins, are predictive of achieving a D90 ≥ 140 Gy.
- Posteriorly reduced seed occupancy and smaller margins also predict successful dose delivery.
- Optimizing these pre-plan dosimetric factors can enhance permanent prostate implant (PPI) outcomes.
More Related Videos
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020